These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 2902613

  • 1. [Effect of almitrine, a chemoreceptor stimulator, on nocturnal hypercapnia and pulmonary artery pressure during O2 respiration in chronic obstructive lung disease].
    Rühle KH, Kempf P, Mössinger B, Klein G, Costabel U, Würtemberger G, Matthys H.
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():411-4. PubMed ID: 2902613
    [No Abstract] [Full Text] [Related]

  • 2. [Nocturnal hypoxemia and hypercapnia in patients with chronic obstructive ventilation disorder. Therapy with almitrine, a peripheral chemoreceptor stimulator].
    Rühle KH, Köhler D, Huber G, Matthys H.
    Prax Klin Pneumol; 1985 Jun; 39(6):197-203. PubMed ID: 2862627
    [No Abstract] [Full Text] [Related]

  • 3. [The effect of almitrine dimesylate on pulmonary hemodynamics in healthy subjects and in patients with chronic obstructive bronchitis].
    Ansquer JC.
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():409-10. PubMed ID: 2902612
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Isocapnic ventilatory response to almitrine in patients with chronic hypercapnia (author's transl)].
    Hannhart B, Peslin R, Bohadana AB, Jansen da Silva JM, Pino J.
    Bull Eur Physiopathol Respir; 1979 Jun; 15 Suppl():195-205. PubMed ID: 45311
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of 2 and 4 l/min oxygen breathing on pulmonary artery pressure, blood gases and sleep stages in patients with chronic obstructive lung disease.
    Rühle KH, Klein D, Köhler D, Costabel U, Matthys H.
    Eur J Respir Dis Suppl; 1986 Jun; 146():443-9. PubMed ID: 3096760
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of oral almitrine on the distribution of VA/Q ratio in chronic obstructive lung diseases (author's transl)].
    Castaing Y, Manier G, Varène N, Guénard H.
    Bull Eur Physiopathol Respir; 1981 Jun; 17(6):917-32. PubMed ID: 7032629
    [Abstract] [Full Text] [Related]

  • 17. Undetermined utility of almitrine.
    Patz D.
    Chest; 1987 May; 91(5):794. PubMed ID: 2882957
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Almitrine dimesylate (vectarion)--the first representative of a new group of "synergetic" drugs--and its use in pulmonary pathology].
    Mihalţan F.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987 May; 36(3):209-19. PubMed ID: 2894713
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.